Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$11.6 - $17.35 $296,960 - $444,160
-25,600 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$8.4 - $15.0 $53,760 - $96,000
6,400 Added 33.33%
25,600 $387,000
Q2 2017

Aug 14, 2017

BUY
N/A
19,200
19,200 $170,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $183M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.